Pharmagy ApS: Financial statements 2023
CVR: 41488514
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharmagy ApS (CVR 41488514) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,791,349 and a net result of DKK 807,787 compared with DKK 731,124 the year before. That is an increase of 4.7% compared with the year before. Equity in the 2023 report amounted to DKK 1,906,832. The solvency ratio was 73.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,791,349
- Profit/Loss
- DKK 807,787
- Equity
- DKK 1,906,832
- Total Assets
- DKK 2,590,822
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmagy ApS has published its annual report for 2022. Gross profit came to DKK 2,666,390, and the net result was DKK 731,124.
About Pharmagy ApS
Pharmagy ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2020. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kirsten Bjerrum and Lars Bøndergaard. The company is owned by LKSynergy ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,097,834 and a net result of DKK 966,279 compared with DKK 1,080,195 the year before. Equity in the 2025 report amounted to DKK 3,553,305.